589 related articles for article (PubMed ID: 21497177)
1. Cell selectivity, mechanism of action and LPS-neutralizing activity of bovine myeloid antimicrobial peptide-18 (BMAP-18) and its analogs.
Lee EK; Kim YC; Nan YH; Shin SY
Peptides; 2011 Jun; 32(6):1123-30. PubMed ID: 21497177
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity, bactericidal mechanism and LPS-neutralizing activity of the cell-penetrating peptide pVEC and its analogs.
Nan YH; Park IS; Hahm KS; Shin SY
J Pept Sci; 2011 Dec; 17(12):812-7. PubMed ID: 21956793
[TBL] [Abstract][Full Text] [Related]
3. Design of novel indolicidin-derived antimicrobial peptides with enhanced cell specificity and potent anti-inflammatory activity.
Nan YH; Bang JK; Shin SY
Peptides; 2009 May; 30(5):832-8. PubMed ID: 19428758
[TBL] [Abstract][Full Text] [Related]
4. Effect of the hydrophobicity to net positive charge ratio on antibacterial and anti-endotoxin activities of structurally similar antimicrobial peptides.
Rosenfeld Y; Lev N; Shai Y
Biochemistry; 2010 Feb; 49(5):853-61. PubMed ID: 20058937
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, antimicrobial activity and LPS-interaction properties of SB041, a novel dendrimeric peptide with antimicrobial properties.
Bruschi M; Pirri G; Giuliani A; Nicoletto SF; Baster I; Scorciapino MA; Casu M; Rinaldi AC
Peptides; 2010 Aug; 31(8):1459-67. PubMed ID: 20438783
[TBL] [Abstract][Full Text] [Related]
6. Cell selectivity and anti-inflammatory activity of a Leu/Lys-rich alpha-helical model antimicrobial peptide and its diastereomeric peptides.
Wang P; Nan YH; Yang ST; Kang SW; Kim Y; Park IS; Hahm KS; Shin SY
Peptides; 2010 Jul; 31(7):1251-61. PubMed ID: 20363271
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial specificity and mechanism of action of disulfide-removed linear analogs of the plant-derived Cys-rich antimicrobial peptide Ib-AMP1.
Wang P; Bang JK; Kim HJ; Kim JK; Kim Y; Shin SY
Peptides; 2009 Dec; 30(12):2144-9. PubMed ID: 19778562
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relations of parasin I, a histone H2A-derived antimicrobial peptide.
Koo YS; Kim JM; Park IY; Yu BJ; Jang SA; Kim KS; Park CB; Cho JH; Kim SC
Peptides; 2008 Jul; 29(7):1102-8. PubMed ID: 18406495
[TBL] [Abstract][Full Text] [Related]
9. Investigating the effects of positive charge and hydrophobicity on the cell selectivity, mechanism of action and anti-inflammatory activity of a Trp-rich antimicrobial peptide indolicidin.
Nan YH; Park KH; Park Y; Jeon YJ; Kim Y; Park IS; Hahm KS; Shin SY
FEMS Microbiol Lett; 2009 Mar; 292(1):134-40. PubMed ID: 19191872
[TBL] [Abstract][Full Text] [Related]
10. Effect of disulphide bond position on salt resistance and LPS-neutralizing activity of α-helical homo-dimeric model antimicrobial peptides.
Nan YH; Shin SY
BMB Rep; 2011 Nov; 44(11):747-52. PubMed ID: 22118542
[TBL] [Abstract][Full Text] [Related]
11. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
12. Cell selectivity and mechanism of action of short antimicrobial peptides designed from the cell-penetrating peptide Pep-1.
Zhu WL; Hahm KS; Shin SY
J Pept Sci; 2009 Sep; 15(9):569-75. PubMed ID: 19455552
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action and specificity of antimicrobial peptides designed based on buforin IIb.
Jang SA; Kim H; Lee JY; Shin JR; Kim DJ; Cho JH; Kim SC
Peptides; 2012 Apr; 34(2):283-9. PubMed ID: 22306477
[TBL] [Abstract][Full Text] [Related]
15. Prokaryotic selectivity and LPS-neutralizing activity of short antimicrobial peptides designed from the human antimicrobial peptide LL-37.
Nan YH; Bang JK; Jacob B; Park IS; Shin SY
Peptides; 2012 Jun; 35(2):239-47. PubMed ID: 22521196
[TBL] [Abstract][Full Text] [Related]
16. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
17. Structure-function study of cathelicidin-derived bovine antimicrobial peptide BMAP-28: design of its cell-selective analogs by amino acid substitutions in the heptad repeat sequences.
Ahmad A; Asthana N; Azmi S; Srivastava RM; Pandey BK; Yadav V; Ghosh JK
Biochim Biophys Acta; 2009 Nov; 1788(11):2411-20. PubMed ID: 19735644
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of the anti-inflammatory activity of temporin-1Tl-derived antimicrobial peptides by tryptophan, arginine and lysine substitutions.
Rajasekaran G; Kamalakannan R; Shin SY
J Pept Sci; 2015 Oct; 21(10):779-85. PubMed ID: 26311041
[TBL] [Abstract][Full Text] [Related]
19. Design of hybrid β-hairpin peptides with enhanced cell specificity and potent anti-inflammatory activity.
Liu Y; Xia X; Xu L; Wang Y
Biomaterials; 2013 Jan; 34(1):237-50. PubMed ID: 23046754
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial peptide P18 inhibits inflammatory responses by LPS- but not by IFN-gamma-stimulated macrophages.
Nan YH; Jeon YJ; Park IS; Shin SY
Biotechnol Lett; 2008 Jul; 30(7):1183-7. PubMed ID: 18327539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
